MilliporeSigma
  • Home
  • Search Results
  • Antidiabetic property of Symplocos cochinchinensis is mediated by inhibition of alpha glucosidase and enhanced insulin sensitivity.

Antidiabetic property of Symplocos cochinchinensis is mediated by inhibition of alpha glucosidase and enhanced insulin sensitivity.

PloS one (2014-09-04)
Kalathookunnel Antony Antu, Mariam Philip Riya, Arvind Mishra, Karunakaran S Anilkumar, Chandrasekharan K Chandrakanth, Akhilesh K Tamrakar, Arvind K Srivastava, K Gopalan Raghu
ABSTRACT

The study is designed to find out the biochemical basis of antidiabetic property of Symplocos cochinchinensis (SC), the main ingredient of 'Nisakathakadi' an Ayurvedic decoction for diabetes. Since diabetes is a multifactorial disease, ethanolic extract of the bark (SCE) and its fractions (hexane, dichloromethane, ethyl acetate and 90% ethanol) were evaluated by in vitro methods against multiple targets relevant to diabetes such as the alpha glucosidase inhibition, glucose uptake, adipogenic potential, oxidative stress, pancreatic beta cell proliferation, inhibition of protein glycation, protein tyrosine phosphatase-1B (PTP-1B) and dipeptidyl peptidase-IV (DPP-IV). Among the extracts, SCE exhibited comparatively better activity like alpha glucosidase inhibition (IC50 value-82.07 ± 2.10 µg/mL), insulin dependent glucose uptake (3 fold increase) in L6 myotubes, pancreatic beta cell regeneration in RIN-m5F (3.5 fold increase) and reduced triglyceride accumulation (22% decrease) in 3T3L1 cells, protection from hyperglycemia induced generation of reactive oxygen species in HepG2 cells (59.57% decrease) with moderate antiglycation and PTP-1B inhibition. Chemical characterization by HPLC revealed the superiority of SCE over other extracts due to presence and quantity of bioactives (beta-sitosterol, phloretin 2'glucoside, oleanolic acid) in addition to minerals like magnesium, calcium, potassium, sodium, zinc and manganese. So SCE has been subjected to oral sucrose tolerance test to evaluate its antihyperglycemic property in mild diabetic and diabetic animal models. SCE showed significant antihyperglycemic activity in in vivo diabetic models. We conclude that SC mediates the antidiabetic activity mainly via alpha glucosidase inhibition, improved insulin sensitivity, with moderate antiglycation and antioxidant activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tannic acid, puriss., meets analytical specification of USP, powder
Sigma-Aldrich
Tannic acid, ACS reagent
Sigma-Aldrich
3-Isobutyl-1-methylxanthine, ≥99% (HPLC), powder
Sigma-Aldrich
3-Isobutyl-1-methylxanthine, ≥99%, BioUltra
Sigma-Aldrich
Ile-Pro-Ile, ≥97% (HPLC)
Sigma-Aldrich
Quercetin, ≥95% (HPLC), solid
USP
Quercetin, United States Pharmacopeia (USP) Reference Standard
Supelco
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
Beta-sitosterol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Tannic acid, Source: Chinese natural gall nuts
Sigma-Aldrich
Tannic acid
Sigma-Aldrich
Rosiglitazone, ≥98% (HPLC)
Dexamethasone, British Pharmacopoeia (BP) Assay Standard
Sigma-Aldrich
Dimethyl sulfoxide, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethyl sulfoxide, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
Dimethyl sulfoxide, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
Dimethyl sulfoxide, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethyl sulfoxide, ReagentPlus®, ≥99.5%
Supelco
β-Sitosterol, certified reference material, 100 μg/mL in chloroform
Sigma-Aldrich
β-Sitosterol, ≥70%
Sigma-Aldrich
Dimethyl sulfoxide solution, 50 wt. % in H2O
Sigma-Aldrich
Acarbose, ≥95%
Supelco
Dimethyl sulfoxide, analytical standard
Supelco
Dexamethasone, VETRANAL®, analytical standard
Sigma-Aldrich
Dexamethasone, tested according to Ph. Eur.
Supelco
Gallic acid, certified reference material, TraceCERT®
Supelco
Oleanolic acid, analytical standard
Supelco
β-Sitosterol, analytical standard
Sigma-Aldrich
Dimethyl sulfoxide, anhydrous, ≥99.9%